Literature DB >> 646259

Resistant hypertension: diagnosis and management.

R W Gifford, R C Tarazi.   

Abstract

Fortunately, hypertension resistant to a good drug regimen is rare. When hypertension fails to respond to medical treatment there is usually another explanation, such as poor patient compliance, excessive salt ingestion, drug interactions, spuriously high office readings, or an unsuspected secondary cause for the hypertension. Management of resistant hypertension can be aided by identifying the hemodynamic and humoral mechanisms responsible for its resistance and redesigning the therapeutic regimens accordingly. When they become available, two investigational drugs, minoxidil and an oral converting enzyme inhibitor, both of which lower total peripheral resistance, will offer a new approach to controlling truly resistant hypertension.

Entities:  

Mesh:

Year:  1978        PMID: 646259     DOI: 10.7326/0003-4819-88-5-661

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

Review 1.  Resistant or refractory hypertension: are they different?

Authors:  Rodrigo Modolo; Ana Paula de Faria; Aurélio Almeida; Heitor Moreno
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

Review 2.  Resistant Hypertension: Mechanisms and Treatment.

Authors:  Andrew Y Hwang; Eric Dietrich; Carl J Pepine; Steven M Smith
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

3.  Predictors of resistant hypertension in an unselected sample of an adult male population in Italy.

Authors:  Antonio Barbato; Ferruccio Galletti; Roberto Iacone; Francesco P Cappuccio; Giovanni Rossi; Renato Ippolito; Antonella Venezia; Eduardo Farinaro; Pasquale Strazzullo
Journal:  Intern Emerg Med       Date:  2011-03-10       Impact factor: 3.397

4.  [Comparison of oral diazoxide and minoxidil in refractory hypertension].

Authors:  A Meier; P Weidmann; Z Glück; G Keusch; M Grimm; I Minder; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-07-01

Review 5.  Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.

Authors:  Tanja Dudenbostel; Mohammed Siddiqui; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190

6.  Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.

Authors:  Krishna K Gaddam; Mari K Nishizaka; Monique N Pratt-Ubunama; Eduardo Pimenta; Inmaculada Aban; Suzanne Oparil; David A Calhoun
Journal:  Arch Intern Med       Date:  2008-06-09

7.  Nadolol in combination with indapamide and xipamide in resistant hypertensives.

Authors:  S Dean; M J Kendall; S Potter; M H Thompson; D A Jackson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Diuretic treatment of resistant hypertension.

Authors:  L E Ramsay; J H Silas; S Freestone
Journal:  Br Med J       Date:  1980-10-25

9.  Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering.

Authors:  Steven M Smith; Matthew J Gurka; Almut G Winterstein; Carl J Pepine; Rhonda M Cooper-DeHoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-07       Impact factor: 3.738

10.  Resistant Hypertension: A Real Entity or a Phantom Diagnosis?

Authors:  Costas Thomopoulos; George Skalis; Thomas Makris
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-17       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.